Product
Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) Vaccine and Haemophilus Influenzae Type B Conjugate Vaccine
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Phase III, Single Center, Randomized, Blind, and Positive Control Clinical Trial to Evaluate the Immunogenicity and Safety of Diphtheria, Tetanus and Acellular Pertussis (Component) Combined Vaccine (Adsorbed) in 3-month-old InfantsStatus: Recruiting, Estimated PCD: 2025-05-25